Cargando…

Response to: Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome

Detalles Bibliográficos
Autores principales:	Eisengart, J.B., King, K.E., Shapiro, E., Whitley, C.B., Muenzer, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005457/ https://www.ncbi.nlm.nih.gov/pubmed/32055445 http://dx.doi.org/10.1016/j.ymgmr.2020.100570

Ejemplares similares

The nature and impact of neurobehavioral symptoms in neuronopathic Hunter syndrome
por: Eisengart, J.B., et al.
Publicado: (2019)

Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome
por: Grant, Nathan
Publicado: (2020)

Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses
por: Barone, Rita, et al.
Publicado: (2018)

Natural history of cognitive development in neuronopathic mucopolysaccharidosis type II (Hunter syndrome): Contribution of genotype to cognitive developmental course
por: Seo, Joo-Hyun, et al.
Publicado: (2020)

Issues of COVID-19-related distance learning for children with neuronopathic mucopolysaccharidoses
por: Eisengart, Julie B., et al.
Publicado: (2021)

Pebbling of skin: Cutaneous marker of Hunter syndrome
por: Srinivas, Sahana M., et al.
Publicado: (2017)

Management of a difficult airway in Hunters syndrome
por: Jain, Aditi, et al.
Publicado: (2022)

Hunter's syndrome and the airway: Implications for the anesthesiologist - A correspondence
por: Chatterjee, Nilay, et al.
Publicado: (2017)

Beneath the floor: re-analysis of neurodevelopmental outcomes in untreated Hurler syndrome
por: Shapiro, Elsa G., et al.
Publicado: (2018)

The neurobehavioral phenotype in mucopolysaccharidosis Type IIIB: An exploratory study
por: Shapiro, E., et al.
Publicado: (2016)

Home treatment in paediatric patients with Hunter syndrome: the first Italian experience
por: Ceravolo, Ferdinando, et al.
Publicado: (2013)

Hunter Island Group Phlebovirus in Ticks, Australia
por: Gauci, Penelope J., et al.
Publicado: (2015)

Airway Findings in Patients with Hunter Syndrome Treated with Intravenous Idursulfase
por: De Vuyst, Richard, et al.
Publicado: (2023)

The definition of neuronopathic Gaucher disease
por: Schiffmann, Raphael, et al.
Publicado: (2020)

Antibodies against Rickettsia spp. in Hunters, Germany
por: Jansen, Andreas, et al.
Publicado: (2008)

Neuronopathic Gaucher disease: Beyond lysosomal dysfunction
por: Arévalo, Nohela B., et al.
Publicado: (2022)

A pediatric neurobehavioral treatment challenge
por: Whitley, Lisa E., et al.
Publicado: (2020)

Chagas Disease in Ancient Hunter-Gatherer Population, Brazil
por: Lima, Valdirene S., et al.
Publicado: (2008)

Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: A survey-based study
por: Koto, Yuta, et al.
Publicado: (2023)

A juvenile case of bow hunter’s syndrome due to a bone fragment from an osteophyte of the atlas
por: Huang, Shuaihao, et al.
Publicado: (2023)

Epidemiologic Questions from Anthrax Outbreak, Hunter Valley, Australia
por: Durrheim, David N., et al.
Publicado: (2009)

Timing is everything: Clinical courses of Hunter syndrome associated with age at initiation of therapy in a sibling pair
por: Grant, Nathan, et al.
Publicado: (2022)

Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II?
por: Vollebregt, Audrey A. M., et al.
Publicado: (2021)

A longitudinal study of neurocognition and behavior in patients with Hurler-Scheie syndrome heterozygous for the L238Q mutation
por: Ahmed, Alia, et al.
Publicado: (2019)

Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art
por: de Castro, María José, et al.
Publicado: (2021)

The Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS) Questionnaire: item reduction and further validation
por: Wiklund, Ingela, et al.
Publicado: (2014)

The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensus
por: Muenzer, Joseph, et al.
Publicado: (2011)

Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome
por: Eisengart, Julie B., et al.
Publicado: (2017)

A thromboembolic mechanism in bow hunter's stroke: Importance of hemodynamic evaluation by ultrasonography during head rotation
por: Eura, Nobuyuki, et al.
Publicado: (2020)

Letter to the Editor Regarding “Predictors of Failure for Nonoperative Management of Spinal Epidural Abscess” by Hunter et al
por: Kitov, Borislav, et al.
Publicado: (2021)

Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease Mouse
por: Sun, Ying, et al.
Publicado: (2011)

Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases
por: Jakóbkiewicz-Banecka, Joanna, et al.
Publicado: (2013)

Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses
por: Baydakova, Galina, et al.
Publicado: (2020)

Clinical Aspects of Neurobehavioral Symptoms of Dementia
por: Yang, YoungSoon, et al.
Publicado: (2020)

Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment
por: Hendriksz, Christian J., et al.
Publicado: (2015)

Bow hunter syndrome
por: Kühn, Anna Luisa, et al.
Publicado: (2022)

Successful therapy for protein-losing enteropathy caused by chronic neuronopathic Gaucher disease
por: Mhanni, A.A., et al.
Publicado: (2015)

Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
por: Narita, Aya, et al.
Publicado: (2016)

Identification of a Biomarker in Cerebrospinal Fluid for Neuronopathic Forms of Gaucher Disease
por: Zigdon, Hila, et al.
Publicado: (2015)

Qualitative analysis of patient interviews on the burden of neuronopathic Gaucher disease in Japan
por: Koto, Yuta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jrhl5s0ni642ihvmuu1g3dscju